Cancer Stem Cells

  • Marcello Maugeri Saccà
  • Vito D’Andrea
  • Angelo Pulcini
  • Ruggero De Maria
Part of the Updates in Surgery book series (UPDATESSURG, volume 0)


Far from being a new concept, the belief that cancer might originate from stem cells dates back to the mid-19th century when Rudolf Virchow proposed that cancer arises from embryo-like cells, based on the histologic similarity between embryonic and cancer tissues. This hypothesis was later extended by Cohnheim and Durante, who postulated that adult tissues contain embryonic remnants that usually lie dormant, but can be activated to give rise to a tumor. This original view, formerly referred to as the embryonic rest theory, has been updated with the cancer stem cell hypothesis, according to which a vicious stem cell-like subpopulation generates a tumor through the deregulation of the self-renewal process. However, the proof-of-concept was provided more than a century later with the identification of leukemiainitiating stem cells in the peripheral blood of acute myeloid leukemia patients [1]. Ever since, the cancer stem cell theory has gained identity and different tissue-specific cancer stem cells (CSCs) have been isolated from both big killers, and rare cancers. These studies were based on a similar experimental approach, which combined fluorescence-activated cell sorting (FACS analysis) of primary tumor cells with antibodies against specific cell-surface markers and serial orthotropic transplantation into immunocompromised mice. Although different operational definitions of CSCs have been proposed, four properties are in general adopted to define them: (i) expression of a distinctive repertoire of cell surface markers for isolation and purification; (ii) formation of tumorspheres in suspension culture; (iii) tumorigenic capacity in immunocompromised mice, as opposed to all other cellular subsets; and (iv) generation of a heterogeneous cancer tissue closely resembling the original


Androgen Receptor Cancer Stem Cell Colonic Stem Cell Cancer Stem Cell Theory 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Bonnet D, Dick JE (1997) Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3:730–737CrossRefPubMedGoogle Scholar
  2. 2.
    Liu R, Wang X, Chen GY et al (2007) The prognostic role of a gene signature from tumorigenic breast-cancer cells. N Engl J Med 356:217–226CrossRefPubMedGoogle Scholar
  3. 3.
    Glinsky GV, Berezovska O, Glinskii AB (2005) Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer. J Clin Invest 115:1503–1521CrossRefPubMedGoogle Scholar
  4. 4.
    Mitsutake N, Iwao A, Nagai K (2007) Characterization of side population in thyroid cancer cell lines: cancer stem-like cells are enriched partly but not exclusively. Endocrinology 148:1797–1803CrossRefPubMedGoogle Scholar
  5. 5.
    Calvi LM, Adams GB, Weibrecht KW et al (2003) Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 425:841–846CrossRefPubMedGoogle Scholar
  6. 6.
    Epstein EH (2008) Basal cell carcinomas: attack of the hedgehog, Nat Rev Cancer 8:743–754CrossRefPubMedGoogle Scholar
  7. 7.
    Oliver TG, Read TA, Kessler JD et al (2005) Loss of patched and disruption of granule cell development in a pre-neoplastic stage of medulloblastoma. Development 132:2425–2439CrossRefPubMedGoogle Scholar
  8. 8.
    Reya T, Clevers H (2005) Wnt signalling in stem cells and cancer. Nature 434:843–850CrossRefPubMedGoogle Scholar
  9. 9.
    Hennessy BT, Gonzalez-Angulo AM, Stemke-Hale K (2009) Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics. Cancer Res 69:4116–4124CrossRefPubMedGoogle Scholar
  10. 10.
    Balic M, Lin H, Young L et al (2006) Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype. Clin Cancer Res 12:5615–5621CrossRefPubMedGoogle Scholar
  11. 11.
    Saini V, Shoemaker RH (2010) Potential for therapeutic targeting of tumor stem cells. Cancer Sci 101:16–21CrossRefPubMedGoogle Scholar
  12. 12.
    Bao S, Wu Q, Sathornsumetee S et al (2006) Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. Cancer Res 66:7843–7848CrossRefPubMedGoogle Scholar
  13. 13.
    Alvero AB, Fu HH, Holmberg J et al (2009) Stem-like ovarian cancer cells can serve as tumor vascular progenitors. Stem Cells 27:2405–2413CrossRefPubMedGoogle Scholar
  14. 14.
    Calabrese C, Poppleton H, Kocak M et al (2007) A perivascular niche for brain tumor stem cells. Cancer Cell 11:69–82CrossRefPubMedGoogle Scholar
  15. 15.
    Hermann PC, Huber SL, Herrler T et al (2007) Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 1:313–323CrossRefPubMedGoogle Scholar
  16. 16.
    Sweeney T, Mailänder V, Tucker A et al (1999) Visualizing the kinetics of tumor-cell clearance in living animals. Proc Natl Acad Sci U S A 96:12044–12049CrossRefPubMedGoogle Scholar
  17. 17.
    Shaner NC, Campbell RE, Steinbach PA et al (2004) Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp red fluorescent protein. Nat Biotechnol 22:1567–1572CrossRefPubMedGoogle Scholar
  18. 18.
    Louie AY, Huber MM, Ahrens ET et al (2000) In vivo visualization of gene expression using magnetic resonance imaging. Nat Biotechnol 18:321–325CrossRefPubMedGoogle Scholar
  19. 19.
    Ricci-Vitiani L, Lombardi DG, Pilozzi E et al (2007) Identification and expansion of human colon-cancer-initiating cells. Nature 445:111–115CrossRefPubMedGoogle Scholar
  20. 20.
    Dalerba P, Dylla SJ, Park IK et al (2007) Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci USA 104:10158–10163CrossRefPubMedGoogle Scholar
  21. 21.
    Huang EH, Hynes MJ, Zhang T et al (2009) Aldehyde dehydrogenase1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Res 69:3382–3389CrossRefPubMedGoogle Scholar
  22. 22.
    Al-Hajj M, Wicha MS, Benito-Hernandez A et al (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 100:3983–3988CrossRefPubMedGoogle Scholar
  23. 23.
    Ginestier C, Hur M, Charafe-Jauffret E et al (2007) ALDH1 is a marker of normal and malignant breast stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1:555–567CrossRefPubMedGoogle Scholar
  24. 24.
    Li X, Lewis MT, Huang J et al (2008) Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. J Natl Cancer Inst 100:672–679CrossRefPubMedGoogle Scholar
  25. 25.
    Bapat SA, Mali AM, Koppikar CB, Kurrey NK (2005) Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer. Cancer Res 65:3025–3029PubMedGoogle Scholar
  26. 26.
    Szotek PP, Pieretti-Vanmarcke R, Masiakos PT et al (2006) Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian inhibiting substance responsiveness. Proc Natl 103:11154–11159CrossRefGoogle Scholar
  27. 27.
    Ferrandina G, Bonanno G, Pierelli L et al (2008) Expression of CD133-1 and CD133-2 in ovarian cancer. Int J Gynecol Cancer 18:506–514CrossRefPubMedGoogle Scholar
  28. 28.
    Ho MM, Ng AV, Lam S et al (2007) Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Res 67:4827–4833CrossRefPubMedGoogle Scholar
  29. 29.
    Eramo A, Lotti F, Sette G et al (2008) Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ 15:504–514CrossRefPubMedGoogle Scholar
  30. 30.
    Li C, Heidt DG, Dalerba P et al (2007) Identification of pancreatic cancer stem cells. Cancer Res 67:1030–1037CrossRefPubMedGoogle Scholar
  31. 31.
    Shah AN, Summy JM, Zhang J et al (2007) Development and characterization of gemcitabine-resistant pancreatic tumor cells. Ann Surg Oncol 14:3629–3637CrossRefPubMedGoogle Scholar
  32. 32.
    Berman DM, Karhadkar SS, Maitra A et al (2003) Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours. Nature 425:846–851CrossRefPubMedGoogle Scholar
  33. 33.
    Collins AT, Berry PA, Hyde C et al (2005) Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 65:10946–10951CrossRefPubMedGoogle Scholar
  34. 34.
    Chen CD, Welsbie DS, Tran C et al (2004) Molecular determinants of resistance to antiandrogen therapy. Nat Med 10:33–39CrossRefPubMedGoogle Scholar
  35. 35.
    Singh SK, Clarke ID, Terasaki M et al (2003) Identification of a cancer stem cell in human brain tumors. Cancer Res 63:5821–5828PubMedGoogle Scholar
  36. 36.
    Wang J, Sakariassen PO, Tsinkalovsky O et al (2008) CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells. Int J Cancer 122:761–768CrossRefPubMedGoogle Scholar
  37. 37.
    Bao S, Wu Q, McLendon RE et al (2006) Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444:756–760CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Italia 2011

Authors and Affiliations

  • Marcello Maugeri Saccà
    • 2
  • Vito D’Andrea
    • 1
  • Angelo Pulcini
    • 1
  • Ruggero De Maria
    • 2
  1. 1.Department of Surgical SciencesSapienza University of RomeRomeItaly
  2. 2.Department of Hematology, Oncology and Molecular MedicineIstituto Superiore di SanitàRomeItaly

Personalised recommendations